Treatment of extensive stage small cell bronchogenic carcinoma. Effects of variation in intensity of induction chemotherapy

The American Journal of Medicine

Volumn 75, Issue 6, 1983, Pages 993-1000

  Brower, Martin ^a   Ihde, Daniel C ^a   Johnston Early, Anita ^a   Bunn Jr , Paul A ^a   Cohen, Martin H ^a   Carney, Desmond N ^a   Makuch, Robert W ^a   Matthews, Mary J ^a   Radice, Peter A ^a   Minna, John D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; LOMUSTINE; METHOTREXATE; VINCRISTINE;

ADVERSE DRUG REACTION; BLOOD AND HEMOPOIETIC SYSTEM; BONE MARROW DEPRESSION; CANCER COMBINATION CHEMOTHERAPY; CARDIOTOXICITY; CHEMOTHERAPY; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; DRUG DOSE; DRUG THERAPY; HEART; HUMAN; INTOXICATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG CARCINOMA; MUCOSA INFLAMMATION; NERVOUS SYSTEM; NEUROPATHY; NEUROTOXICITY; RESPIRATORY SYSTEM; RESPONSE; SEPSIS; SMALL CELL CARCINOMA; SURVIVAL; THERAPY;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, BRONCHOGENIC; CARCINOMA, SMALL CELL; CLINICAL TRIALS; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; VINCRISTINE;

EID: 0021021135     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(83)90880-X     Document Type: Article

References (24)

1. Dose: a critical factor in cancer chemotherapy
2. Intensive chemotherapy of small cell bronchogenic carcinoma
3. Small cell bronchogenic carcinoma: a prolonged remission following chemotherapy
4. Treatment of bronchogenic carcinoma. II. Small cell
5. Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma
6. Thymosin fraction V and intensive combination chemotherapy: prolonging the survival of patients with small-cell lung cancer
7. Amplification of circulating granulocytemonocyte stem cell numbers following chemotherapy in patients with extensive small cell carcinoma of the lung
8. Nonparametric estimation from incomplete observations
9. Evaluation of survival data and two new rank-order statistics arising in its consideration
10. Nonparametric confidence limits for survival probabilities and median survival time
11. Prognostic implications of stage of disease and sites of metastases in patients with small cell carcinoma of the lung treated with intensive combination chemotherapy
12. Possible enhancement of vincristine neuropathy by VP-16
13. Intensive induction chemotherapy in 54 patients with small cell carcinoma of the lung
14. Doxorubicin, cyclophosphamide, and VP-16-213 (ACE) in the treatment of small cell lung cancer
15. High dose cyclophosphamide (C) in the induction (IND) chemotherapy of small cell lung cancer (SCLC): minor improvement in rate of remission and survival (abstr)
16. CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival
17. Central nervous system metastases in small call bronchogenic carcinoma
18. Prophylactic cranial irradiation in small cell carcinoma of the lung: a randomized study
19. Long term survivors with small cell carcinoma of the lung
20. Long term survival in small cell carcinoma of the lung
21. Small cell lung cancer complete remission and improved survival
22. Chemotherapy of small cell bronchogenic carcinoma
23. Reinduction prolongs survival in complete responders (CR) with small cell lung cancer (abstr)